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Abstract 
Background: Cancer affects millions of individuals globally, with a mortality rate of over 
eight million people annually. Although palliative care is often provided outside of specialist 
services, many people require, at some point in their illness journey, support from specialist 
palliative care services, for example, those provided in hospice settings. This transition can 
be a time of uncertainty and fear and there is a need for effective interventions to meet the 
psychological and supportive care needs of people with cancer that cannot be cured. While 
Acceptance and Commitment Therapy (ACT) has been shown to be effective across diverse 
health problems, robust evidence for its effectiveness in palliative cancer populations is not 
extensive.  
Method: This mixed-methods study uses a single-case experimental design with embedded 
qualitative interviews to pilot test a novel intervention for this patient group. Between 14 and 
20 patients will be recruited from two hospices in England and Scotland. Participants will 
receive five face-to-face manualised sessions with a psychological therapist. Sessions are 
structured around teaching core ACT skills (Openness, Awareness and Engagement) as a way 
to deal effectively with challenges of transition into specialist palliative care services. 
Outcome measures include: cancer-specific quality of life (primary outcome) and distress 
(secondary outcome), which are assessed alongside measures of psychological flexibility. 
Daily diary outcome assessments will be taken for key measures, alongside more detailed 
weekly self-report, through baseline, intervention and one-month follow-up phases. After 
follow-up, participants will be invited to take part in a qualitative interview to understand 
their experience of taking part, and acceptability and perceived effectiveness of the 
intervention and its components.  
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Discussion: This study is the first investigation of using ACT with terminally ill patients at 
the beginning of their transition into palliative treatment. Using in-depth single-case 
approaches, we will refine and manualise intervention content by the close of the study for 
use in follow-up research trials. Our long-term goal is then to test the intervention as 
delivered by non-psychologist specialist palliative care practitioners thus broadening the 
potential relevance of the approach.  
 
Trial Registration: Open Science Framework, 46033. Registered 19 April 2018, 
https://share.osf.io/registration/46033-EBD-837 
 
List of abbreviations: ACT – Acceptance and Commitment Therapy  
 
Key words: palliative care, Acceptance and Commitment Therapy, cancer, single-case 
design 
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Background 
Globally, over 14 million new cases of cancer are diagnosed each year, and 8.4 million 
deaths were attributed to cancer in 2012 alone [1]. Finding out that cancer is no longer 
curable can be psychologically distressing for both patients and their family [2]. Indeed, 
recognition of distress as the sixth ‘vital' sign to monitor in cancer care is receiving increased 
attention [3, 4]. The subsequent transition following a referral into specialist palliative care 
services when cancer is no longer curable can be a time of uncertainty and fear. When living 
with uncertainty, it can become difficult to satisfactorily plan for the future [5] which is 
crucial at this stage of cancer [6]. Quality of life may also be negatively affected [7]. There is, 
therefore, a clear need for effective interventions to meet the psychological and supportive 
care needs of cancer patients at this point in their illness [8] which the current evidence base 
does not provide [9].  
 
Acceptance and Commitment Therapy (ACT: [10]) is a form of cognitive behavioural 
therapy that has a good evidence base for the type of psychological problems often reported 
by people affected by cancer, for example, anxiety and depression [11], but specific evidence 
for its effectiveness in palliative cancer populations is lacking/limited [12]. Within the ACT 
model, distress is understood as being a normal reaction to a difficult situation, and ACT 
supports people to become more resilient [13] and self-compassionate [14] when in distress. 
ACT is underpinned by a number of therapeutic processes, including mindfulness, acceptance 
and cognitive defusion [15], which then support the individual to be more engaged with 
values-based living [12]. Within a palliative care setting, this framework is suggested as a 
helpful approach in supporting people to identify what is important to them and to help them 
live a life of meaning, quality and value, even when faced with challenging circumstances. 
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Overall, ACT encourages people to be psychologically flexible [16], which is thought may 
help with distress management in people with incurable cancer [17].   
 
A number of cross-sectional studies have demonstrated associations between ACT 
therapeutic processes, distress and quality of life outcomes in cancer patients [18, 19]. Other 
work has shown that psychological flexibility correlates also with positive adjustment 
indicators, such as benefit finding [20]. Intervention studies have reported feasibility and 
acceptability of ACT self-help interventions [21] and there is early evidence for the 
effectiveness of interventions in both curative and advanced cancer samples [22]. 
 
Whilst there are sound theoretical reasons why ACT should be useful in palliative care 
settings [12], we are aware of just one study which is feasibility testing the use of ACT for 
patients who are more established within the palliative care pathway [17]. Research is 
therefore needed to establish its broader empirical support [9]. In addition, although there 
have been recent studies exploring mechanisms and moderators of ACT interventions (e.g. 
increases in psychological flexibility and reduction in experiential avoidance) [23, 24, 25], 
these mechanisms, and how they relate to specific therapeutic components, are not well 
understood. Importantly, these processes have not yet been thoroughly explored in the 
context of a terminal cancer diagnosis, a setting which brings unique personal and 
environmental challenges.  
 
This work aims to develop, and pilot test, a brief, manualised psychological intervention to 
provide support to people with an incurable cancer diagnosis who are at the transition into 
specialist palliative care services. We aim to further explore the feasibility of delivering this 
intervention within a hospice and community environment. Our planned study allows us to 
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tentatively test the effectiveness of the intervention in a small sample of participants using a 
single-case, controlled design. We will explore mechanisms and processes of improvement in 
patient wellbeing through intervention delivery and short-term follow-up to further refine the 
intervention for subsequent research and clinical use. We are also monitoring data on 
acceptability, recruitment, attrition, and eligibility in order to determine best practices 
moving forward into larger trials.  
 
Methods/design  
This study uses a mixed-methods approach to both design and pilot test a novel psychological 
intervention for this patient group. A mixed-methods approach is appropriate for this research 
question as quantitative data can be supplemented by ideographic narrative data that records 
the unique perspective of patients in the trial [26]. Mixed-methods also allow researchers to 
evaluate the saliency and acceptability of defined constructs and components during a pilot 
test [27], ensuring suitability prior to larger, more expensive trials. We will incorporate 
patient feedback through the full development process (at design, intervention development, 
and evaluation) to ensure that the intervention is acceptable to the patient group for whom it 
is designed [28]. 
 
The intervention will be delivered individually, using a single-case experimental design [29], 
to community-based patients accessing specialist hospice day and community services at two 
Marie Curie clinical services in England and Scotland. Single-case experimental designs are 
appropriate for this kind of study because they allow for highly controlled intervention 
delivery [30], and a patient-centred, in-depth analytic strategy. We use them here to facilitate 
process modelling and accurate intervention development [31] in line with MRC guidance for 
the development of complex interventions [32]. They are idiographic in nature, and also 
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allow for the detailed examination of effects through quantification of outcome and process 
variables [33]. 
 
The primary aim of a single-case experimental design is to indicate that any observed change 
in outcome results from the application of the intervention. Single-case designs are 
commonly used in psychological intervention research [34] and have proven utility in cancer 
research [35]. As an intervention study, this is a Phase I ‘modelling’ study [32] that will lead 
on to a later feasibility trial of the developed, manualised, intervention. As such, delivery of 
the current study will be under optimal conditions (i.e. by trained psychologists/ 
psychotherapists) to ensure high levels of fidelity and content quality, in addition to creating 
a therapeutically and ethically safe environment for participants and intervention facilitators. 
Establishing proof of principle in this way is a vital first step in fully developing and 
evaluation a complex intervention [32]. 
 
Intervention: rationale and development 
Previous research, including pilot work conducted by our team [18, 20, 23, 19], demonstrates 
that ACT is a psychological intervention that is both relevant and acceptable to people with 
cancer. Intervention content for this specific study was initially developed through a thorough 
review of literature describing common challenges and psychological problems faced by 
cancer patients at the stage of advanced cancer/palliative care. The literature describes 
common themes around: loss of control [36]; fear, understanding and acceptance [37]; rapid 
loss of independence, shifting relationship dynamics and the importance of balancing life 
tasks against limited time available [38]. 
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Alongside this conceptual review we used general ACT intervention guidance [e.g. 39, 40], 
resources available on the Association for Contextual Behavioural Science website 
(www.contextualscience.org), and ACT intervention development expertise within the study 
research team to plan treatment strategies and methods likely to be effective in promoting 
psychological flexibility: effective living, in the presence of the kinds of psychological 
responses described in the literature above. The intervention was developed by two ACT 
experts (DG & NHW) and then iteratively refined in consultation with the broader research 
group and our study patient and stakeholder reference group (including two cancer patients, a 
family carer, and a healthcare professional working in a hospice setting). 
 
The intervention manual consists of five sessions (see table 1). Each is designed for one-to-
one, face-to-face delivery, and to last approximately 45 to 60 minutes per session. At this 
early stage of intervention development work we have designed the intervention to be 
delivered by an experienced therapist with either a doctoral level clinical psychology 
qualification or a Masters level CBT qualification (or equivalent) conferring active British 
Association of Cognitive and Behavioural Therapy accreditation. Intervention facilitators are 
not required to have prior experience of working in a palliative care setting; during induction 
they will undertake the standard hospice induction which includes observation and 
orientation in the hospice. Previous training and experience in delivering ACT-based 
intervention is desirable, though not essential for this study. 
 
In addition to local hospice induction, training will be provided by the intervention authors 
(NHW & DG) through use of self-study materials, simulated video role-play, and practice 
role-play opportunities. The level of training provided will be tailored dependent on the prior 
experience and skills of the individuals appointed to this role. Before delivery of the 
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intervention to study participants, therapists will undertake a competency assessment where 
their delivery of the intervention (with a simulated patient) will be video-recorded and 
assessed against a previously validated ACT Rating Scale [39]. Therapists are required to 
score at least 90 (corresponding to “average competence”) before delivering the intervention 
in the clinical setting. Where this level of competency is not achieved, further training will be 
provided. There will be one therapist at each clinical site to ensure continuity for participants 
recruited, and consistency of delivery between participant for added methodological quality. 
Clinical supervision will be provided by an existing member of the team who is suitably 
qualified for this role (JSt). 
 
Table 1 to appear here.  
 
Module A takes the majority of the first intervention session. Session two then covers module 
B plus one of the ACT-specific modules (C, D or E) in an order determined by the therapist 
to best meet the needs and priorities identified and negotiated with the participant in session 
one. Sessions three and four cover the remaining module content (C, D or E), with module F 
delivered at one-month follow-up. The level of flexibility inherent in the design will allow for 
greater understanding of delivery differences between participants, and a more refined 
understanding of which elements produce what kinds of changes in outcome and process 
variables.  
 
Each week, participants are provided with homework exercises to build skills. These include 
sheets to help prompt mindfulness activities, defusion exercises, values creation, and 
committed actions based on identified values. Homework exercises also include short audio 
recordings to prompt mindfulness, values contact, and defusion skills.  Summary sheets of 
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the key themes of each session are provided to participants at the end of each session to be 
used as aide-memoire; a modified version of this is also provided to be given to any family 
members or carers who have questions about the intervention content. The family/carer 
summary sheets are for information only rather than intending to be used for personal benefit. 
 
Participants: eligibility criteria and referral into the study 
People over 16 years of age who have been told that they have an incurable cancer diagnosis, 
and who are referred to specialist hospice day or community services at two hospice sites 
(one in England and one in Scotland) will be identified by hospice-based community nursing 
teams and invited to participate (see table 2). Eligible participants must have a life 
expectancy of four months or more, and although limited to those affected by cancer, is not 
restricted to any particular cancer type. Seven to ten participants will be recruited from each 
recruitment site with the aim of completing the intervention with fourteen participants in 
total. 
 
Table 2 to appear here.  
 
Information and consent processes 
Community nurses who undertake an initial assessment on referral into the hospice services 
will provide an overview of the study and provide a study pack which includes a patient 
information sheet, information for family members, and a study consent form. Participants 
will be given time to consider the study invitation and then, if interested, will be asked to 
provide consent to be contacted by the research team. At this point, the researcher will 
contact participants by telephone and: (i) explain the study in greater detail, covering 
intervention aims and assessment; (ii) give participants an opportunity to ask questions; (iii) 
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explain practicalities such as session frequency, location and transport; and (iv) arrange a first 
appointment. Written informed consent will be taken as part of the first session with the 
therapist.  
  
Procedure 
Ethical approval has been obtained from an NHS Research Ethics Committee (IRAS Project 
ID: 239683), in addition to relevant approvals from the research governance committees at 
Marie Curie Hospice Liverpool and Marie Curie Hospice Edinburgh. These two hospices 
have been selected pragmatically due to proximity to the collaborating University research 
sites, however, they afford a comparison between delivery across (a) two UK countries, and 
(b) settings both with (Edinburgh) and without (Liverpool) a dedicated in-house hospice 
research lead. 
 
Intervention sessions will take place at the hospice and last between 45 and 60 minutes. 
During the assessment interview, participants will complete baseline measures described 
below. These measures are repeated at the start of each subsequent intervention session. 
Daily process and QoL data will be gathered using either the smart-phone based app 
(Personal Analytics Companion (PACO); [40]), or a paper and pencil booklet equivalent. 
Completion of daily diaries will be monitored by the research team and where three 
consecutive recordings are missed, the researcher will contact the participant by telephone to 
discuss barriers to completion. In the case of non-app-based diary data collection, we will not 
be able to undertake such regular checking (this can happen only at face-to-face meetings 
with the therapist for these participants) and thus smart-phone data collection methods will be 
strongly encouraged. 
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During the final intervention session, the therapist will explain the purpose of the follow-up 
qualitative interview, providing both written information and an opportunity to answer any 
questions that participants might have about this. Consent will be collected at that time by the 
therapist. Two weeks later, participants will be contacted by the researcher. Interviews will 
be conducted on a one-to-one basis either in the hospice (face-to-face) or via telephone. 
Interviews will be recorded for later transcription and analysis. The interview schedule is 
designed to help participants to express their experiences of taking part, acceptability of 
intervention content, and perceived effectiveness of the intervention and its components. In 
addition, the interview will also ask about caregivers’ experiences during the intervention.  
 
On completion of the study, participants will be provided with a study debrief sheet, 
including information about getting additional support. Procedures for dealing with any 
distress due to the interview have been carefully considered and pathways into further 
support outlined and agreed with the relevant clinical care teams. 
 
Once the study has completed in each clinical site, we will invite all staff members involved 
with study (recruitment, site-specific study management etc.) to a focus groups where we will 
undertake discussions and data collection on any challenges and barriers that they 
experienced during the study. We will also seek their opinions about acceptability, 
effectiveness and impact on the patient and their family, and suggestions for how the study 
design should be improved for later trials. 
 
Data collection 
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Weekly self-report questionnaires will be administered throughout the intervention to assess 
changes in quality of life (our primary outcome), distress (secondary outcome) and ACT 
intervention processes (as potential mediating variables).  
 
Daily diaries will be used to attempt more sensitive and specific measurement of process 
change. Daily recordings are known to produce more valid and accurate results than 
retrospective summary reports [41]. Participants will have the choice to access these daily 
recordings either via a smart-phone app, or paper versions to ensure ease of access. The use 
of a smart-phone app (PACO; [40]) for daily data collection is relatively novel within 
palliative care trials and so this pilot data will allow us to conclude whether this is a feasible 
alternative to paper-based data collection methods for similar work. 
 
Data will also be collected on the number of patients approached about the study, the number 
then recruited, attrition, and reasons for non-eligibility in order to inform later feasibility and 
effectiveness trials.  
 
Primary outcome  
 
Functional Assessment of Chronic Illness Therapy – Palliative Care (weekly) [42] 
The FACIT-pal measures functional quality of life in palliative care. The scale is comprised 
of five domains: physical well-being (7 items); social/family well-being (7 items); emotional 
well-being (6 items); functional well-being (7 items); and additional concerns (19 items). 
Each item is measured on a Likert scale of 0 (not at all) – 4 (very much). Cronbach’s alpha 
has previously been reported at .90 for the full 27-item scale, and .78 to .87 for sub-scales, 
suggesting strong internal consistency [43].  
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Secondary outcomes 
 
Distress Thermometer (weekly) [44]  
The DT is a single-item measure of distress on a scale from 0 (no distress) to 10 (extreme 
distress). It has been validated as a world-wide measure of distress in people affected by 
cancer [45].  
 
Comprehensive Assessment of Acceptance & Commitment Therapy Processes (weekly) [46] 
The CompACT is a measure of the postulated mechanism of action and process of ACT. It 
consists of 23 items grouped into three sub-scales (openness to experience, behavioural 
awareness, and valued action) which map closely onto our three core intervention sessions 
(modules C, D, and E). Items are scored on a seven-point Likert scale, ranging from 0 
(strongly disagree) to 6 (strongly agree). Psychometric properties of the CompACT have 
been shown to be adequate [46]. 
  
Brief Acceptance Measure (daily) [47]  
The BAM is a three-item measure of psychological flexibility, specifically designed for use 
in single-case experimental designs and similar daily diary studies. Participants rate the 
previous 24 hours on each of three dimensions of openness, awareness and engagement in 
valued activities on a 1 to 10 numeric scale. Scales are anchored at either end with indicative 
statements (e.g. 1 = struggling with thoughts, feelings and physical sensations versus 10 = 
open to thoughts, feelings and physical sensations).  The BAM total score has an alpha of .71 
and correlates strongly with the CompACT (r = .57, p < .001). The BAM is also sensitive to 
brief interventions designed to increase psychological flexibility in healthy adults. 
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Single-item QoL (daily) 
A single quality of life item will be used to measure overall health. This is an item in which 
participants rate their health on a scale from 0 (worst imaginable health state) to 100 (best 
imaginable health state).  
 
Feasibility outcomes 
Although this study is not designed as a Phase II feasibility study, relevant data will be 
collected on: number of patients screened for eligibility; number patients potentially eligible; 
number of patients recruited; and, percentages of consented participants who complete the 
intervention and follow-up. Percentage drop-out, deaths during the study, and missing data 
(i.e. how much of the self-report questionnaires were completed by participants) will be 
monitored and recorded throughout the study. This information, together with the pilot 
acceptability data, will be used to inform the next phase of our research – a full feasibility 
study – by clarifying whether this is a potentially appropriate setting and timepoint in the 
patient pathway to deliver a psychological intervention. Undertaking full feasibility testing at 
this stage is inappropriate given that we don’t yet have fully developed, acceptable, 
intervention content. 
 
Sample size 
Potentially high rates of attrition need to be considered in any palliative care research when 
determining the sample size [51]. We aim to recruit 14 patients who complete the full 
intervention. Given a high probability of attrition, we expect to recruit approximately 20 
patients allowing for such attrition. This sample size is more than sufficient for a single-case 
research design [48,49] which purposely recruit only small samples given their idiographic 
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focus. All participants who complete the intervention will be invited to participate in the 
qualitative interview. 
 
Data analysis 
Quantitative data: Analysis of daily diary data (BAM and QoL single-item) will include 
visual analysis, calculation of stability envelope, between-phase mean level change and the 
percentage non-overlapping data, as is standard to single-case methodology [48]. Advances 
in statistical analysis of single-case experimental design data now allow researchers to 
calculate p values and effect sizes from single-case data, and to aggregate these across single 
cases, using metanalytic methods [49]; such analyses will be undertaken where data permit 
their use. These data will provide tentative and preliminary indications of effectiveness and 
will be reported with 95% confidence intervals where relevant. Weekly questionnaire data 
will be analysed with visual analysis and level change [50]. 
 
Management of missing data: We assume that some participants will be unable to complete 
the weekly and daily self-report questionnaires at certain times during the study period. 
Given that the weekly questionnaires will be filled out immediately before each session and 
administered by the therapist, we anticipate no participants missing any weekly 
questionnaires. However, it is likely that participants will miss opportunities to record the 
daily measures. Members of the hospice team will be made aware if a participant misses 
three or more daily recordings in a row in order to determine if the reason is due to health 
deterioration prior to the research team following-up with the participant directly to discuss 
any technical issues in recording this data.  
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Qualitative data: Follow-up interviews with participants will be audio-recorded, transcribed 
verbatim, and analysed using a framework analysis approach [52]. Framework analysis is 
particularly well suited for applied health research that aims to answer specific questions 
within a limited time frame [53]. It allows for the analysis of data thematically while 
undertaking exploratory analysis of the dataset. Staff focus groups will be analysed using this 
same analytic approach. 
 
Manual revision 
Alongside data collection from participants, and the focus groups with hospice staff, we will 
also seek expert peer-review of the manual. The intervention manual will be circulated to 
experts within our own professional networks, including: (a) ACT experts, (b) clinical 
psychologists who do not identify primarily as ACT-oriented, (c) cancer/palliative care 
nurses, and (d) palliative care specialists. We will aim to seek feedback from at least 5 expert 
reviewers who are independent from our project team.  
 
Peer-review feedback will be triangulated with the quantitative and qualitative data from the 
empirical part of this study to inform a revised version of the intervention manual. The 
revised manual will be worked on initially by the original two authors (DG & NHW), and 
then presented to the broader research group and the study patient and stakeholder reference 
group for comments before finalising at the end of the study. 
 
Discussion 
There is a growing appreciation for the need for holistic support for people with cancer that 
cannot cured who are transitioning into specialist palliative care settings; this needs to include 
evidence-based psychological care [22]. Our work aims to build on a small existing literature 
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by pilot testing a novel, brief and manualised ACT-based intervention to improve 
psychological support for this population. Our work will determine whether or not the 
intervention is feasible and acceptable in this setting, and will provide a foundation for 
subsequent research to test intervention efficacy in potentially more scalable formats, such as 
delivery by nurses and allied health professionals, in either group or individual settings.  
 
The use of a mixed method, single-case design will provide both quantitative and narrative 
data that will indicate potential efficacy and mechanism of the intervention, and also allow an 
in-depth analysis of patient experience. This is a rare design choice in psychosocial oncology 
and palliative care research, and we intend for our study to provide an example of how this 
approach can be well-suited to Phase I intervention development and modelling work [32]. 
 
If this development phase proves successful, the next phase in our programme of work will 
be to feasibility test the manualised intervention using potentially more cost-effective means 
of delivery and more conventional, group-based randomised controlled designs. To allow 
this, we will use data collected in this development study to revise content of the intervention 
manual. This pilot work will generate acceptability data, and information on practical 
challenges and potential barriers to uptake and retention, to ensure maximised likelihood of 
success in these follow-on trials.  
 
Key to the success of this study will be our embedded approach of involving people affected 
by cancer [54]. In addition to a patient representative as a grant co-applicant and member of 
the Project Management Group (SM), we have recruited a patient and stakeholder reference 
group who will input on intervention content, pilot trial design, analysis of data, and 
refinement of the intervention manual on study completion. This will be based on more 
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extensive feedback from patient participants in the study who take part in the embedded 
qualitative interviews.  
 
Dissemination plan 
A primary output from this study will be a published, open-access, delivery manual for the 
intervention. Although this won’t have been robustly efficacy tested, we expect the data from 
this study may be sufficient to allow health care professionals to choose whether or not they 
wish to use this immediately. Findings from this study will be published in peer-review 
journal articles and at a range of conferences, including palliative care, psychosocial 
oncology, and psychological intervention audiences for maximised impact. A lay summary 
will be available for participants and their families, and to be circulated to key stakeholder 
organisations.  
Conclusions 
This paper reports a study protocol and so we are limited in the conclusions that we can make 
at this stage. However, the forthcoming results will have high importance for both theory and 
palliative care literatures. Regarding theoretical implications, this study will expand our 
knowledge of how the ACT framework can be adapted and applied to people with cancer that 
cannot be cured, as they transition into palliative care services: this is a previously 
unexplored application of the ACT intervention framework. There is a high need for data-
driven research into how we can best support the psychological and supportive care needs of 
people transitioning into care: our study is the first step in developing a novel intervention to 
fill this crucial research and service-delivery gap. 
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Table 1: Intervention Components 
 
Module Purpose Elements 
A Assessment & 
Engagement 
Warmth, empathy, positive regard. History taking, typical 
responses to transition, beginning baseline monitoring and 
introducing measurement protocol and concepts. 
B Workability Review of typical responses and greater contact with the 
consequences, linking ineffective strategies with control, 
avoidance and cognitive fusion. 
C Awareness Teaching awareness skills, linking to greater behavioural 
choice, mindfulness exercises, 5 senses experience, mindful 
eating a raisin, 10-minute mindfulness audio exercise given for 
homework. 
D Openness Demonstrating the greater effectiveness of willingness to have 
difficult thoughts and feelings and at the same time, stepping 
back from such inner experiences. Using leaves on the stream 
exercise, singing negative thoughts, speaking negative 
thoughts in a funny voice, perspective taking around thoughts, 
kick your buts exercise, ‘I’m having the thought that…’ 
exercise. 
E Engagement Linking behavioural effectiveness with desired outcomes and 
qualities of actions, in order to live with purpose and meaning 
in the end stage of life. Concept of values, and actions, 
sweetspot exercise, the compass metaphor, generating 
hierarchies of difficult actions.  
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F Review & 
ending 
(one month 
follow up) 
Review of progress after 4 weeks of no treatment, barriers to 
practice, anticipation of future challenges and how Open, 
Aware and Engagement skills could be used, behavioural 
rehearsal of effective responses, commitments to next steps. 
Ending contact. 
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Table 2: Protocol for recruitment and intervention delivery 
 
1. Identification of eligible participants by hospice team.  
2. Clinical teams to introduce study during routine visit to hospice/day service within two 
weeks of referral into service: information sheet provided, and consent given to pass contact 
details to research team.  
3. Consent form returned to either clinical team or posted directly to research team. If returned 
to clinical team, to be posted to research team.  
4. Researcher has weekly contact with each clinical team and ensures maintenance of consent 
log each site. Maintains corresponding participant database.  
5. When consent form received by researcher, researcher makes contact with participant to:  
 Provide opportunity for further questions;  
 Establish time frame for intervention delivery; and, 
 Arrange intervention sessions with psychotherapist for relevant site.  
Copy of consent form sent to clinical team to be placed in patient medical record.  
6.  Researcher maintains log of sessions for therapist.  
7. Intervention session 1 (45-60 minutes) covering the assessment and engagement 
components, completion of baseline assessments, and preparing the participant to undertake 
the daily diary recordings.  One week completion of baseline daily diary recordings.  
8.  After one week completion of daily diaries (baseline), Intervention session 2 (30-45 minutes) 
and completion of weekly questionnaires (15 minutes). Daily diary data collection continues. 
9.  Intervention session 3 (30-45 minutes) and completion of weekly questionnaires (15 
minutes). Daily diary data collection continues.  
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10. Intervention session 4 (30-45 minutes) and completion of weekly questionnaires (15 
minutes). Daily diary data collection continues.  
11. Intervention session 5 (follow-up session) approximately 4 weeks later (30-45 minutes) and 
completion of weekly questionnaires (15 minutes). Information sheet and consent form 
given for interview. Daily diary data collection end with this session providing 9 weeks of 
data in total. 
12.  Interview consent form received by research team. Copy provided to clinical team for patient 
medical record.  
13.  Interview conducted by telephone 2 weeks after the end of the intervention (30 minutes).  
  
 
